ACR 2024 Rheumatology Roundup Featuring Drs. Artie Kavanaugh and Jack Cush
Rheumnow Podcast
00:00
Exploring Carbon Footprints of Adalimumab and Biosimilars
This chapter explores the environmental impact of adalimumab and its biosimilars, particularly focusing on their carbon footprints related to packaging and delivery. It highlights the findings that Amgevita has the lowest emissions, while also providing a humorous anecdote about the competitive marketing landscape in the pharmaceutical industry.
Transcript
Play full episode
